What service do you need? Contact Request

NCT05372718

Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

← Clinical trials hub

Registry fields

Overall status: COMPLETED
Conditions: Acute Limb Ischemia
Study type: INTERVENTIONAL
Phase: PHASE3
Primary purpose: TREATMENT
Intervention type: DRUG, PROCEDURE
Interventions: Recombinant non-immunogenic staphylokinase (Fortelyzin®), surgical methods of treatment
Lead sponsor: Supergene, LLC (INDUSTRY)

Cached at: 2026-10-06 06:39:50

View on ClinicalTrials.gov

Brief summary

Objective: to evaluate the efficacy and safety of intra-arterial intrathrombus administration of the recombinant non-immunogenic staphylokinase (Fortelyzin®) in patients with acute limb ischemia (ALI) vs surgery.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report